Replication of herpes simplex virus 1 depends on the γ134.5 functions that facilitate virus response to interferon and egress in the different stages of productive infection

被引:45
作者
Jing, XH [1 ]
Cerveny, M [1 ]
Yang, K [1 ]
He, B [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA
关键词
D O I
10.1128/JVI.78.14.7653-7666.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The ability of the gamma(1)34.5 protein to suppress the PKR response plays a crucial role in herpes simplex virus pathogenesis. In this process, the gamma(1)34.5 protein associates with protein phosphatase 1 to form a large complex that dephosphorylates eIF-2alpha and thereby prevents translation shutoff mediated by PKR. Accordingly, gamma(1)34.5 null mutants are virulent in PKR-knockout mice but not in wild-type mice. However, gamma(1)134.5 deletion mutants, with an extragenic compensatory mutation, inhibit PKR activity but remain avirulent, suggesting that the gamma(1)34.5 protein has additional functions. Here, we show that a substitution of the gamma(1)34.5 gene with the NS1 gene from influenza A virus renders viral resistance to interferon involving PKR. The virus replicates as efficiently as wild-type virus in SK-N-SH and CV-1 cells. However, in mouse 3T6 cells, the virus expressing the NS1 protein grows at an intermediate level between the wild-type virus and the gamma(1)34.5 deletion mutant. This decrease in growth, compared to that of the wild-type virus, is due not to an inhibition of viral protein synthesis but rather to a block in virus release or egress. Virus particles are predominantly present in the nucleus and cytoplasm. Notably, deletions in the amino terminus of the gamma(1)34.5 protein lead to a significant decrease in virus growth in mouse 3T6 cells, which is independent of eIF-2alpha dephosphorylation. In correlation, a series of deletions in the amino-terminal domain impair nuclear as well as cytoplasmic egress. These results indicate that efficient viral replication depends on the gamma(1)34.5 functions required to prevent the PKR response and to facilitate virus egress in the different stages during virus infection.
引用
收藏
页码:7653 / 7666
页数:14
相关论文
共 51 条
[1]   IDENTIFICATION BY ANTIBODY TO A SYNTHETIC PEPTIDE OF A PROTEIN SPECIFIED BY A DIPLOID GENE LOCATED IN THE TERMINAL REPEATS OF THE L-COMPONENT OF HERPES-SIMPLEX VIRUS GENOME [J].
ACKERMANN, M ;
CHOU, J ;
SARMIENTO, M ;
LERNER, RA ;
ROIZMAN, B .
JOURNAL OF VIROLOGY, 1986, 58 (03) :843-850
[2]  
Andreansky S, 1997, CANCER RES, V57, P1502
[3]   The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors [J].
Andreansky, SS ;
He, B ;
Gillespie, GY ;
Soroceanu, L ;
Markert, J ;
Chou, J ;
Roizman, B ;
Whitley, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11313-11318
[4]   The Ebola virus VP35 protein functions as a type IIFN antagonist [J].
Basler, CF ;
Wang, XY ;
Mühlberger, E ;
Volchkov, V ;
Paragas, J ;
Klenk, HD ;
Garcia-Sastre, A ;
Palese, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :12289-12294
[5]   Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication [J].
Bergmann, M ;
Garcia-Sastre, A ;
Carnero, E ;
Pehamberger, H ;
Wolff, K ;
Palese, P ;
Muster, T .
JOURNAL OF VIROLOGY, 2000, 74 (13) :6203-6206
[6]   Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness [J].
Bower, JR ;
Mao, HW ;
Durishin, C ;
Rozenbom, E ;
Detwiler, M ;
Rempinski, D ;
Karban, TL ;
Rosenthal, KS .
JOURNAL OF VIROLOGY, 1999, 73 (05) :3843-3853
[7]   ICP34.5 INFLUENCES HERPES-SIMPLEX VIRUS TYPE-1 MATURATION AND EGRESS FROM INFECTED-CELLS IN-VITRO [J].
BROWN, SM ;
MACLEAN, AR ;
AITKEN, JD ;
HARLAND, J .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :3679-3686
[8]   CELL-TYPE AND CELL STATE DETERMINE DIFFERENTIAL IN-VITRO GROWTH OF NON-NEUROVIRULENT ICP34.5-NEGATIVE HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2 [J].
BROWN, SM ;
HARLAND, J ;
MACLEAN, AR ;
PODLECH, J ;
CLEMENTS, JB .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :2367-2377
[9]   The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34 [J].
Brown, SM ;
MacLean, AR ;
McKie, EA ;
Harland, J .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9442-9449
[10]  
Cassady KA, 1998, J VIROL, V72, P7005